Table 2.
Reported Exposures by Key Patient Characteristics
| Sex | Men (n = 71) | Women (n = 85) | OR (Men vs Women) | 95% CI | P Valuea |
|---|---|---|---|---|---|
| Any exposure | 58 (82) | 43 (51) | 4.37 | 1.99-9.60 | < .001b |
| Occupational exposure | 47 (66) | 12 (14) | 10.14 | 4.50-22.83 | < .001b |
| Mold | 12 (17) | 27 (32) | 0.43 | 0.19-0.98 | .05 |
| Bird | 22 (31) | 20 (24) | 1.45 | 0.67-3.12 | .29 |
| Hobby | 21 (30) | 11 (13) | 2.92 | 1.23-6.94 | .01b |
| Multiple exposures | 40 (56) | 22 (26) | 3.70 | 1.78-7.66 | < .001b |
| Race | White (n = 114) | Black (n = 27) | Hispanic (n = 9) | Asian (n = 6) | OR (White vs Nonwhite) | 95% CI | P Valuec |
|---|---|---|---|---|---|---|---|
| Any exposure | 78 (68) | 14 (52) | 5 (56) | 4 (67) | 1.44 | 0.67-3.11 | .35 |
| Occupational exposure | 45 (39) | 9 (33) | 2 (22) | 3 (50) | 0.87 | 0.35-2.16 | .68 |
| Mold | 30 (26) | 7 (26) | 1 (11) | 1 (17) | 1.52 | 0.63-3.63 | .34 |
| Bird | 38 (33) | 1 (4) | 3 (33) | 0 (0) | 4.24 | 1.38-13.00 | .01b |
| Hobby | 29 (25) | 3 (11) | 0 (0) | 0 (0) | 3.93 | 1.11-13.89 | .03 |
| Multiple exposures | 52 (46) | 6 (22) | 4 (44) | 0 (0) | 2.11 | 0.91-4.91 | .08 |
| Diagnosis | IPF (n = 41) | HP (n = 22) | CTD (n = 66) | IPAF (n = 14) | Other (n = 13) | OR (HP vs non-HP) | 95% CI | P Valuec |
|---|---|---|---|---|---|---|---|---|
| Any exposure | 34 (83) | 20 (91) | 30 (45) | 9 (64) | 8 (62) | 9.49 | 2.02-44.61 | .004b |
| Occupational exposure | 23 (56) | 10 (45) | 15 (23) | 7 (50) | 4 (31) | 2.91 | 0.94-9.03 | .06 |
| Mold | 10 (24) | 12 (55) | 11 (17) | 3 (21) | 3 (23) | 4.29 | 1.65-11.18 | .003b |
| Bird | 19 (46) | 10 (45) | 8 (12) | 2 (14) | 3 (23) | 2.75 | 1.05-7.18 | .04 |
| Hobby | 18 (44) | 8 (36) | 1 (2) | 4 (29) | 1 (8) | 3.35 | 1.17-9.54 | .02 |
| Multiple exposures | 26 (63) | 15 (68) | 9 (14) | 8 (57) | 4 (31) | 5.43 | 1.84-16.03 | .002b |
Values are No. (%) or as otherwise indicated. CTD = connective tissue disease; HP = hypersensitivity pneumonitis; IPAF = interstitial pneumonia with autoimmune features; IPF = idiopathic pulmonary fibrosis.
a
Adjusted for age and pack-years smoking.
b
Significant P value adjusting for multiple hypotheses.
c
Adjusted for age, sex, and pack-years smoking.